Summary
| INTRODUC TI ON
Natural killer (NK) cells are innate lymphocytes that critically function in defense against viral infection and malignancy. They serve these roles through multiple mechanisms that collectively exert both direct antiviral and anti-tumor responses, while also helping to shape the adaptive and innate immune responses. According to current paradigms, NK cells are considered within the innate lymphoid cell (ILC) family, which includes both conventional NK cells and ILCs that primarily reside within tissue and have specialized functions that parallel T cell helper subsets.
1,2 Based upon ficiency, which leads to significant differences in its effect on circulating T cell subsets between mice and humans. [7] [8] [9] [10] Such differences continue to be uncovered, including the recent discovery of human RIPK1 deficiency, which leads to immunodeficiency, gut inflammation, and polyarthritis, a surprisingly different phenotype from the systemic inflammation and early morbidity seen in Ripk1-knockout mice. [11] [12] [13] [14] Finally, the study of patients with PIDs has the potential to provide important therapeutic insights and help in the design and guidance of new treatments for others.
With this in mind, the study of patients with PIDs that affects the NK cell subset has shaped our understanding of uniquely human aspects of immunology. Innate immune cells are finely tuned to respond to environmental cues for their function and homeostasis. While model organisms are an irreplaceable tool in our understanding of the requirements for immunity, we must turn to the human model to fully understand the human system. The differing environs between humans and experimental mice, who are frequently housed in the absence of specific pathogens, are likely at least partially responsible for the functional distinctions between innate immune cell subsets between the species. 15 There is also notable divergent evolution with a number of important of functional orthologues being represented by distinct gene families in humans and mice, such as Ly49 in mice and KIR in humans. 16 As technologies improve for studying specifically human immunology, we can also take advantage of these to drive new investigations into lesser-understood immune subsets, including NK cell subsets, adaptive and memory-like NK cells, and
ILCs.
Here, we will summarize the findings from the study of patients with PIDs that can primarily or solely affect NK cells and place these in the context of our current understanding of human NK cell development and homeostasis. These NKD have traditionally been divided into those that affect maturation, survival, and development, as opposed to those that singularly affect NK cell function without interfering with the former. We are increasingly becoming aware of the complexity of drawing such distinctions, however, and will discuss current thinking about the relationship between phenotype and function in NKD. Similarly, we will also include a brief discussion of select combined immunodeficiencies in which an NK cell abnormality may be a minor component of the immunological phenotype, but provides significant insight into human NK cell biology. While these affect other immune subsets, they additionally provide valuable information about the mechanistic requirements for human NK cells. Finally, we will consider the implication of these findings given the emerging understanding of the relationship between NK cells and ILCs. The careful study of patients with NKD
gives us the opportunity to better understand how inherent defects in NK cell development, differentiation, and function can inform our current understanding of the requirement for this particular subset of human immune cells.
| H UMAN NK CELL DE VELOPMENT, D IFFERENTIATI ON , AND FUN C TI ON
Human NK cells arise from bone marrow hematopoietic precursors, and in both mice and humans, ablation of the bone marrow abrogates NK cell development. [17] [18] [19] While the generation of mature NK cells in bone marrow has been described, it is thought that bone marrow precursors traffic to peripheral tissues, the best described of which is secondary lymphoid tissue, to undergo terminal maturation and subsequently exit to circulation. [20] [21] [22] Despite the first description of this natural history of human NK cells in 2005, it is still poorly understood how these steps of maturation are regulated, and the precise localization and regulation of NK cell generation has not been well defined.
Within peripheral blood, the primary NK cell subset is the CD56 dim subset, which has cytolytic capacity at baseline and is thought to circulate to enable recruitment to sites of infection and inflammation. give rise to CD56 dim NK cells based upon in vitro, in vivo, transplantation, and humanized mouse models. [24] [25] [26] [27] [28] [29] Despite these findings, which include longer telomeres in CD56 bright NK cells 27 and the early appearance of CD56 bright NK cells following transplantation, 28, 29 the mechanism by which this transition is regulated is not defined, and the precise physiological relationship between the two subsets is called into question by recent studies in non-human primates that suggests the two subsets have independent origins. 30, 31 The difficulty in understanding human NK cell development has arisen from several factors. NK cell development and terminal maturation is a process with much greater plasticity than T or B cell development, including much less rigorous tissue restriction. While T and B cell developmental subsets can be spatially and temporally mapped within thymic and bone marrow environments, respectively, NK cell precursors and developmental intermediates in adults can be isolated from a number of sites, including bone marrow, 32 spleen, 32 thymus, [33] [34] [35] [36] intestine, 37 secondary lymphoid tissue, 20, 32, 38 uterus, 39 and liver. 40 With the exception of bone marrow, which generates hematopoietic precursors, none of these sites are critical for the generation of mature circulating NK cells. Instead, it is becoming increasingly clear that NK cell development is shaped by the microenvironment, leading to generation of diverse, tissue-specific subsets with unique functions. 41 This model highlights the plasticity of NK cell precursors, which includes common NK-ILC precursors, and underscores the role that the cytokine and tissue microenvironment play in shaping functionally mature NK cells.
A second factor that has confounded the study of human NK cell development lies in the difficulty in drawing comparisons between mouse and human models. While analogous functional subsets are commonly identified, key differences in receptor expression make this difficult. This includes the lack of CD56 or a known CD56 homologue on murine NK cells. Perhaps, more important is the role that environmental exposure plays in human NK cell maturation. The phenotype of circulating NK cells is frequently described in terms of CD56 bright or CD56 dim subsets; however, careful dissection of peripheral blood NK cells reveals receptor expression that changes through life and in response to immune experiences. These changes include distinct patterns of receptor diversity that are induced in response to genetic and environmental factors, 42 and the formation of adaptive or memory NK cells in response to common viruses.
The best characterized of these is CMV infection, which leads to the generation of an adaptive pool of NK cells that were originally identified as expressing NKG2C, [43] [44] [45] but have also been identified in NKG2C-negative individuals. 46 Further studies have identified other characteristics of these cells, including their down-regulation of the intracellular adapters Syk and FcεRγ and the transcription factors EAT2 and PLZF1. 47, 48 Adaptive NK cells are also present following diverse viral infections including hantavirus, 49 chikungunya virus, 50 and HIV, [51] [52] [53] and memory-like NK cells are generated in response to cytokine stimulation. 54 It is likely that there are additional environmental factors that similarly shape NK cell phenotype and function that are even less well understood and are also not well replicated in mice housed under specific pathogen-free conditions. These could 
| CLINI C AL HALLMARK S OF NK CELL DEFICIEN CIE S
The term NK cell deficiency, or NKD, defines a PIDs in which the major immunological defect is that of the NK cell subset. 77 At present, this includes 6 monogenetic disorders ( is expected that when NK cell phenotype is affected, NK cell function will be measurably diminished, either as a feature of reduced number or aberrant functional maturation. NKD may be defined as "classical" (cNKD) or "functional" (fNKD), with the former referring to cases in which NK cell development or maturation is affected, and the latter referring to aberrant function in the presence of seemingly normal numbers, including distribution of subsets, in peripheral blood. 78 The specific reason for the term "classical" as opposed to "developmental" or "maturational" is that the first reported cases of NKD (which were ultimately genetically solved) were ones in which NK cells were initially reported or subsequently defined as absent or greatly reduced in the peripheral circulation. [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] Clinically, the presentation of NKD is variable; however, the hallmark of NKD is generally considered to be herpesviral infections including varicella zoster virus (VZV), herpes simplex virus (HSV), Epstein-Barr Virus (EBV), and cytomegalovirus (CMV), with these viruses present in almost 60% of reported NKD cases. 78 While some NKD may affect other immune compartments or lead to other clinical phenotypes, the unusual susceptibility to these viruses is a con- have also been described in some patients, and although there is experimental evidence for roles of NK cells in defense against these types of organisms, it is less well understood. Of those patients that have been reported with NKD, almost half had died prematurely, underscoring a likely substantive reporting bias but also the severity their disease. 78 Correlation between NK cell function and the control of viral infections can be additionally defined by the study of GATA2-deficient patients, which demonstrates that decreasing frequency of NK cell counts was associated with increasing complications of disease. 95 While NK cells have an inherent ability to provide surveillance for cancerous cells and powerful anti-tumor functions, the susceptibility to malignancy in NKD patients has been less well defined. This is perhaps in part because of the high morbidity of NKD decreasing the mean lifespan of many of the reported patients. There are, however, susceptibilities to certain malignancies associated with some NKD, specifically those that are driven by oncogenic viruses.
EBV-driven cancers have been described in NKD patients, including lymphomas in GATA2 deficiency, 96 an EBV smooth muscle tumor in a patient with cNKD, 79 and EBV-driven Castleman's disease in two patients with fNKD. 93, 97 HPV-driven dysplasia was detected in 35% of patients with GATA2 deficiency, and HPV-related head and neck cancers have also been observed. 95 The importance of NK cells in the control of malignancy has also been illustrated by the study of 98 This has led to a number of efforts to harness this functionality to improve transplant rates, and there has been an explosion of exciting new NK cell-based therapies that are showing promise in the clinic. 99 Taken together, the severe clinical phenotype of patients with NKD, combined with clinical outcomes of transplant, reinforces the conclusion that NK cells play at least some non-redundant role in human health.
| FUN C TI ONAL NK D (FNKD)
To date, the only example of an NKD that strictly affects function (fNKD) but not maturation, development or more broadly phenotype, is a result of homozygous mutations in FCGRIIIA leading to the protein having an L66H substitution, which has been reported in 3 unrelated patients. 93, 97, 100 No changes in NK cell maturation or other NK cell phenotypic markers were noted; however, all had impaired NK cell cytotoxicity. These patients experienced recurrent HSV and HPV, as well as one with EBV-driven Castleman's disease. Despite CD16's role as the IgG Fc receptor, these patients have only impaired natural cytotoxicity, while their ADCC function is intact. 93, 100 This seemingly paradoxical finding is explained by the fact that the variant amino acid is outside of the CD16 IgG Fc-binding domain and is not predicted to change the structure of that region. It does, however, cause variation in the distal Ig domain of CD16 and interrupts the role of CD16 in stabilizing the activating receptor CD2 at the immunological synapse. 93 Thus, while the ability of this aberrant CD16 to recognize an opsonized target cell is normal, it is unable to be utilized by CD2 when CD2
is engaged at the immunological synapse. This prevents ligated CD2 from accessing CD16 costimulation and inducing CD3ζ signaling downstream of CD16. As a result, the signaling for natural cytotoxicity induced by susceptible target cells is reduced, leading to decreased NK cell killing. While CD16 can be expressed by non-NK cells, neutrophils express a form lacking the intracellular signaling domain as it is replaced with a GPI-linkage. 101 Thus, this defect owing to the variation in the CD16 extracellular domain is likely NK cell specific.
Importantly, while these particular FCGRIIIA mutations do not affect NK cell phenotype, the single amino acid change in these patients disrupts the epitope of CD16 recognized by monoclonal antibody B73.1. Thus, NK cells from the patients harboring the homozygous CD16 mutation can be detected by flow cytometry through loss of detection of CD16 by the B73.1 clone, provided it can still be recognized by a monoclonal antibody outside of the variant domain such as 3G8. 93 This abnormal "dual epitope assay" can help in screening patients for this abnormality, but does not serve as a replacement for direct gene sequencing.
While it is somewhat surprising that to date there is only one fNKD described, the difficulty in defining fNKD lies not necessarily in their rarity, but in identifying the patients themselves as well as 
| CL A SS I C AL NKD (CNKD)
The majority of genetic explanations for NKD that have been published in the peer-reviewed literature (5 to date) are classical NKD, which can also be referred to as developmental NKD. These are defined by impaired NK cell development, which can range from a complete absence of NK cells in peripheral blood to a stable, dysregulated subset distribution most frequently reflected by a low overall number of peripheral blood NK cells. As the primary subsets in peripheral blood, CD56 bright and CD56 dim , also represent stages of NK cell development, the loss of these specific subsets as a result of NKD is informative about the requirements for NK cell development and homeostasis.
| GATA2
Perhaps, the best-known case of NKD was that of a teenage girl, first described in 1989, who had extreme susceptibility to herpesvirus infections. 87 Beginning at the age of 13, she had recurrent and severe infections with CMV, VZV (including varicella pneumonia), and HSV.
Given the described link between NK cells and control of herpesviral infection, [102] [103] [104] NK cell functional testing was performed and revealed that the patient had essentially absent NK cells, accompanied by severely impaired NK cell function. 87 T cell numbers and function were mostly normal, underscoring the observation that human NK cells seemed particularly important for the control of herpesviral infections; an observation in part based upon earlier experience with CMV disease post-transplantation where CTL functions were intact but NK cell cytotoxicity was impaired. 94 The genetic origin of this patient's disease was subsequently found to be a pathogenic heterozygous GATA2 mutation, and this finding was reported with a cohort of other GATA2-deficient patients who had a range of frequencies of NK cells within peripheral blood. 105 This included many patients with <1% NK cells within the lymphocyte gate, as well as those who had higher frequencies of NK cells; however, it should be noted that even patients with NK cell frequencies that fell within normal range had reduced NK cell function as well as aberrant NK cell subsets. 105 A consistent feature of GATA2-deficient NK cell populations is the decreased relative frequency of the CD56 bright subset. [105] [106] [107] [108] The aberration in subset distribution has been identified both in patient peripheral blood and in NK cell subsets that have been differentiated from patient CD34 + hematopoietic stem cells in vitro. This is sur- 95 There additionally is a correlation between decreasing NK cell numbers in the periphery and increasing complications of disease, and asymptomatic carriers of GATA2 mutations are often CMV seronegative and have higher frequencies of NK cells in peripheral blood. 95, 108 Taken together, these observations suggest that viral infection in the face of impaired NK cell homeostasis and function contributes to NK cell attrition and progression of disease. Better delineating the role that viral infection may play in shaping both the NK and stem cell populations will be important for improved therapeutic interventions, given the impaired survival time of patients following the onset of symptoms. 95 Further studies are necessary to better understand the natural history of this complex disease and where NKD fits into the spectrum of clinical possibilities that derive from aberrations of this singular transcription factor.
| CMG helicase mutations: MCM4 and GINS1
Discovery of the cell division cycle (CDC) 45-mini chromosome 
| IRF8
An additional classic case of NK cell deficiency was first published in the Journal of Pediatrics in 1982 and described a family whose children were highly susceptible to EBV infection. 88 In a family of 4 children, 1 died as a result of severe EBV, a second had life-threatening prolonged illness and died several years later, and a third was hospitalized extensively and has continued ongoing sequelae. The fourth child was unaffected. Whole exome sequencing and analysis identified biallelic variants in the IRF association domain (IAD) of IRF8 that segregated appropriately within the family and were novel and damaging. 92 Additional families were identified, including a child with homozygous variants in IRF8 and disseminated BCG disease, and a second child with compound heterozygous mutations and recurrent respiratory infections. 116, 117 Similarly to MCM4 and GINS1 deficiency, the distinguishing fea- 92 Further study of these mice showed that they are particularly susceptible to LCMV infection and malignancy and that generation of adaptive NK cells in these mice following infection is impaired. 123 In both murine 123 
| RTEL1
Biallelic mutations in regulator of telomerase elongation 1 (RTEL1) lead to Hoyeraal-Hreidarsson syndrome, which includes dyskeratosis congenita, bone marrow failure, cerebellar hypoplasia, intrauterine growth retardation, developmental delay, and short telomeres. [124] [125] [126] Immunodeficiency is also frequently present, including progressive lymphopenia affecting T, B, and NK cell subsets. 124 However, in at least one case, homozygous RTEL1 mutations led to isolated NKD in a young girl with fatal varicella infection. 82, 90 While NK cell subsets were not measured, total NK cell numbers were significantly decreased and NK cell cytotoxic function was impaired.
82
Other lymphocyte subsets were unaffected, and no extra-immune features were noted. It is unclear why NK cells were the sole affected population in this case, particularly as the mutation that was identified in the index case is a founder mutation within the Ashkenazi Jewish population. 90 This may be an additional manifestation of the sensitivity of NK cells to genetic lesions that affect proliferation and DNA replication, as seen in helicase mutations. It may also reflect a tendency, as with GATA2 deficiency, for disorders of bone marrow failure to selectively progress to NKD in advance of broader immune abnormalities and cellular deficiencies.
| PRIMARY IMMUNE DEFICIEN CIE S WITH NK CELL FE ATURE S
In addition to NKD, in which NK cell aberration is the primary, major- 
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| Familial hemophagocytic lymphohistiocytosis
One of the most easily understood causes of impaired NK cell func- shown to be unusually large, 193, 194 this was recently advanced further for granules in NK cells from patients with LYST mutations. 144, 195 New studies have demonstrated that the size of lytic granules in Chediak-Higashi syndrome patient NK cells can be a physical barrier to their directed secretion, as they are unable to transverse the cortical actin network located below the NK cell synaptic membrane. 195 This network has been shown to regulate granule exocytosis 196 and the fact that large granules cannot find egress is further evidence to support the actin meshwork as a checkpoint that lytic granules must navigate and pass. These studies complement those that show that mutations in the actin-regulating protein coronin 1A that cause PIDs lead to impaired NK cell function due to increased density of actin at the NK cell lytic synapse (discussed further below).
170
A second emerging theme in the cell biology of HLH is the recent description of patients with disease-causing RAB27A mutations who have normal skin and hair pigmentation. [197] [198] [199] To date, there have been three cohorts of patients described in which this is the case. In the first two, novel mutations lead to selective disruption of the interaction between RAB27A and Munc13-4, but not melanophilin. This leads to impaired immune cell secretion, but normal melanocyte function. 197, 198 In the third cohort of 5 patients from 5 families, whole genome sequencing identified distinct transcriptional start sites differentially utilized by lymphocytes and melanocytes. 199 Mutations in the start site used primarily by lymphocytes lead to HLH; however, melanocyte function is retained through the utilization of the alternate transcriptional start site. Both of these led to complex and difficult to diagnose cases, particularly the second in which whole exome sequencing failed to uncover the cause of disease, and the tell-tale hypopigmentation associated with Griscelli's syndrome Type 2 was not present.
| Actin regulators
Wiskott-Aldrich syndrome (WAS) was among the earliest primary immune deficiencies to be described and is classically described as a triad of eczema, thrombocytopenia, and infections. 200, 201 Early cell biological studies identified the role for WASp in cytoskeletal regulation; however, these led the way for the description of the requirement for actin remodeling in NK cell immune synapse formation and function. 169 Impaired NK cell function in WAS patients leads to unusual susceptibility to herpesviral infections, with clinically relevant infections in approximately one-third of WAS patients. 202 The functional defect in actin remodeling at the NK cell synapse can be corrected by addition of IL-2, which activates alternative actin remodeling pathways through WAVE2. however, NK cells are present with a seemingly normal phenotype.
Patients frequently have unusually severe EBV infections and EBVdriven lymphomas, which can likely be attributed to the demonstrated functional impairment of NK cells in peripheral blood. 170 In contrast to WASp, Arp2, and other actin nucleation-promoting factors, however, immunological synapse formation occurs in NK cells from patients with coronin 1A mutations, and MTOC and granule polarization to the synapse are unaffected. 170 Instead, decreased NK cell function can be attributed to impaired translocation of lytic granules across the cortical actin network to enable membrane fusion and exocytosis. Reduced actin remodeling in the absence of coronin 1A function leads to an actin barrier that physically impedes the transit of granules through minimally sized clearances in the actin network. As opposed to mutations that lead to gross actin defects, these changes are only detectable on the nanoscale. The increased optical resolution afforded by super-resolution microscopy will likely lead to the identification of similar defects that result in fine changes in molecular tuning that translate to significant biological effects. 208 
| Recent developments in combined immune deficiencies having phenotypic and functional NK cell impairments
While the majority of PIDs that are associated with an NK cell abnormality include both functional and phenotypic aberrations, a number of relevant developments have been reported since recent reviews on NK cells in PIDs have been published. 78, 127, 128 Several of these are reviewed here in order to be able to contextualize the derivative biology in light of advances in the NK cell field. Both STAT deficiencies and mutations in the PI3K signaling pathway lead to combined immune deficiencies, with multilineage impairments reflective of the conserved requirements for these pathways in immune cell function.
In each case, there is also an NK cell component that contributes to clinical phenotype in many patients. While an in-depth review of these diseases is beyond our current scope, it is again worth considering how these contribute to an NK cell phenotype that is abnormal in both phenotype and function.
| Gain-of-function mutations in the PI3K signaling pathway
The PI3K signaling pathway is a ubiquitous and important pathway ing NK cell dysfunction. 157 There are also genes that control cellular metabolism that affect NK cell development at early stages, such as MTHFD1, ADA, and AK2 mutations. 129, 154, 155 These likely affect lineage commitment in bone marrow or peripheral tissue; however, the mechanism by which they exert function is poorly understood.
Similarly, homozygous mutations in IKZF1, which encodes the master transcriptional regulator Ikaros, lead to profound multilineage cytopenias that in some patients include reduced NK cell numbers 148 ;
heterozygous IKZF1 mutations also lead to reduced frequency of circulating NK cells in some patients. 149 Even though an abnormality of NK cells in these conditions represents a minor immunological aberration, the study of NK cells in these conditions can yield often unexpected biological insights into NK cell biology.
| EMERG ING THEME S IN NK CELL DEFICIEN C Y
| Helicase mutations, proliferation, and cell cycle
Given the rarity of NKD, there is an increasingly strong signal around the theme of genes associated with cell cycle and proliferation in NKD. Mutations in MCM4 and GINS1 all lead to a strikingly similar Given the emerging importance of NK cells as tools for immune therapy, 99 and the demonstrated role that they play in the setting of transplant, 235 it will be critical to better understand the relationship between proliferation, transcription, cellular fitness, and NK cell maturation and function. The advantage of doing so will hopefully be the ability to make improvements to these cells as therapeutic vehicles.
| Adaptive NK cells and NKD
The identification of a persistent adaptive NK cell population in GATA2-deficient patients 108 deficiencies, would be of interest. Given the recently described link between STAT4-mediated induction of IRF8 leading to Zbtb32-mediated cell proliferation and the generation of adaptive NK cells in mice, 123 it would also be of interest to more closely examine the presence of adaptive NK cells in patients with helicase complex mutations. As clonal expansion is a prerequisite for generation of an adaptive immune response, it will be important to determine whether impaired proliferation has an impact on the generation of long-lived memory-like NK cells in these patients. It would also be invaluable to be able to probe the function and inherent value of these populations in the human system via expanded specific study of these disorders.
| What can NKD and ILCD tell us about the requirements for NK and ILC development?
The decreased frequency of circulating ILC subsets in some patients with GINS1 deficiency was exciting as it was the first report of a common cause of NK and ILC deficiency. 91 Given that non-NK cell ILC subsets are predominantly found in tissue, the question of the relevance of circulating ILCs in peripheral blood had dogged the field for some time. However, the discovery of ILC precursors and mature subsets in circulation has made the measurement of ILCs in peripheral blood more common and informative. 68 It will be important, as tools for ILC detection and classification continue to be developed, that we define normal ranges of ILC subsets and better understand how these are affected by age, infection, transplant, and immunodeficiency. This will include, when possible, the cataloguing of these cells in tissues and the comprehensive study of their phenotype and ontology, an undertaking that has already been significantly advanced by single cell analyses. 236 The relationship between NK cells and ILCs is plastic, and the study of this relationship is a rapidly evolving field. The identity of common precursors, particularly in humans, has been difficult to definitively define and study. An NK-and ILC-restricted precursor, the common innate lymphoid precursor (CILP), has been identified in tissue and can be identified by expression of RORγT. 237 In addition, it is widely cited that ILC3 subset generation arises from a CD34 + RORγT + precursor, and ILC3 is defined by RORγT expression. 3, 238 However, the presence of conventional NK cells in patients with immune deficiency as a result of mutations in the RORC gene encoding RORγ and RORγT suggests that RORC is not required for conventional human NK cell development. 68, 239 In addition, in two patients examined with biallelic mutations in RORC, ILC precursors were present in peripheral blood and gave rise to functional conventional NK cells, ILC1, and ILC2 subsets, as well as IL-13-, but not IL-17-producing, ILC3s. 68 Given that RORC deficiency affects all IL-17-producing subsets, including Th17 cells, it is not an isolated ILCD.
The pan-cytopenic impairment in IL-17 production accounts for the overwhelming susceptibility to candidiasis in these patients; in addition, decreased IFNγ production by αβ and γδ T cell subsets leads to increased susceptibility to Mycobacterium infection. 239 While transcription factors such as GATA3, EOMES, and
RORγT are used to define ILC subsets, ILCs are highly reliant on cytokine signaling for their development and homeostasis, and their primary function is cytokine production. As such, their phenotype and function can be changed in response to inflammatory conditions, and they are thought to play a role in the pathology of IBD, psoriasis, and rheumatoid diseases. Within the context of PIDs, the emerging understanding of diseases with interferon gene signatures includes an awareness of the effect that this has on ILC subsets. In patients with CVID, the expansion of an IFNγ + circulating ILC subset is found in patients with non-infectious complications, which frequently include autoimmune cytopenias, lymphoid hyperplasia, and granulomatous disease. 240 Therefore, particularly as new diseases emerge with interferon signatures and existing conditions are better delineated, it will be important to place the ILC subsets in the context of both immunity and pathology in these diseases.
In contrast to RORC-deficient patients, the reduced frequency of both conventional NK cells and ILCs, as well as MAIT and NKT cells, in some, but not all, GINS1-deficient patients suggests a common requirement for GINS1 in their development. 91 Should the require- patients was found to be primarily manifested in the periphery, as opposed to at the bone marrow precursor level, suggesting that the overall defect may be a result of dysregulated balance between apoptosis and proliferation in the periphery. 91 Mouse models of the effect of reduced helicase or DNA damage pathway function, however, reveal skewing of multipotent progenitors at the earliest stages, suggesting there may be effects on lineage potential at the earliest stages of hematopoiesis. 241 In addition, it is likely that these may become more damaging as the effects of aging and, potentially, inflammation change the function and kinetics of the stem cell population. 232, 233 It will be of value to determine the changes in gene 
